“Profiling human tumor-specific T cell responses for cancer biomarker discovery”

Presented by Evan Newell, Ph.D.

Professor
Vaccine and Infectious Disease Division, Fred Hutch

Joint Professor, Herbold Computational Biology Program
Public Health Sciences Division, Fred Hutch

Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch &
Pathogen-Associated Malignancies Integrated Research Center (PAM IRC), Fred Hutch

Learn more about Dr. Newell...
Dr. Evan Newell is an immunologist who develops and employs new technologies for accurately identifying specific biological signatures of human health and disease, including cancer and infectious diseases. He and his team work with blood and tissue samples, using mass cytometry and other single-cell analysis methods to better understand how the specificities of immune T cells influence their roles in clinically productive responses against pathogens or cancers.